Terms: = Pancreatic cancer AND UBR5, EDD, 51366, ENSG00000104517, EDD1, KIAA0896, HYD, MGC57263, DD5, O95071, FLJ11310
6 results:
1. E3 ubiquitin ligase ubr5 promotes gemcitabine resistance in pancreatic cancer by inducing O-GlcNAcylation-mediated EMT via destabilization of OGA.
Du Y; Yang Z; Shi H; Chen Z; Chen R; Zhou F; Peng X; Hong T; Jiang L
Cell Death Dis; 2024 May; 15(5):340. PubMed ID: 38755129
[TBL] [Abstract] [Full Text] [Related]
2. NIR Fluorescent/Photoacoustic Bimodal Imaging of Ferroptosis in pancreatic cancer Using Biothiols-Activable Probes.
Li L; Zhang Z; Zhou L; Ge H; Zhao Y; Gong Y; Mao GJ; Liu H
Anal Chem; 2024 May; 96(18):7248-7256. PubMed ID: 38655839
[TBL] [Abstract] [Full Text] [Related]
3. Enhanced anticancer potency of hydroxytyrosol and curcumin by PLGA-PAA nano-encapsulation on PANC-1 pancreatic cancer cell line.
Jadid MFS; Shademan B; Chavoshi R; Seyyedsani N; Aghaei E; Taheri E; Goleij P; Hajazimian S; Karamad V; Behroozi J; Sabet MN; Isazadeh A; Baradaran B
Environ Toxicol; 2021 Jun; 36(6):1043-1051. PubMed ID: 33496383
[TBL] [Abstract] [Full Text] [Related]
4. E3 ubiquitin ligase ubr5 promotes pancreatic cancer growth and aerobic glycolysis by downregulating FBP1 via destabilization of C/EBPα.
Chen L; Yuan R; Wen C; Liu T; Feng Q; Deng X; Du Y; Peng X
Oncogene; 2021 Jan; 40(2):262-276. PubMed ID: 33122826
[TBL] [Abstract] [Full Text] [Related]
5. [SCLEROUSIS CHOLANGITIS AT THE AUTOIMMUNE PANCREATITIS PATIENT].
Gavrilina NS; Sedova GA; Kosyura SD; Fedorov IG; Ilchenko LY; Storozhakov G
Eksp Klin Gastroenterol; 2015; (7):78-84. PubMed ID: 26817126
[TBL] [Abstract] [Full Text] [Related]
6. Novel peptide conjugates for tumor-specific chemotherapy.
Langer M; Kratz F; Rothen-Rutishauser B; Wunderli-Allenspach H; Beck-Sickinger AG
J Med Chem; 2001 Apr; 44(9):1341-8. PubMed ID: 11311056
[TBL] [Abstract] [Full Text] [Related]
